<PAGE>
                                       
                     SECURITIES AND EXCHANGE COMMISSION
                           WASHINGTON, D.C. 20549
                                 FORM 10-QSB

(Mark One)
  X   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
----- EXCHANGE ACT OF 1934

For the quarterly period ended                  June 30, 1997              
                               ----------------------------------------------

----- TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
      EXCHANGE ACT OF 1934

For the transition period  from                        to                  
                                ----------------------    -------------------

Commission file number                         0-16286                       
                       ------------------------------------------------------

                              MEDPLUS CORPORATION
-----------------------------------------------------------------------------
            (Exact name of registrant as specified in its charter)

          Delaware                                    95-4082020          
-----------------------------------------------------------------------------
(State or other jurisdiction of          (IRS Employer identification number)
 incorporation or organization)

8  S. Nevada Ave.,  Ste. 204, Colorado Springs,  Colorado            80903   
-----------------------------------------------------------------------------
(address of principle executive offices)                           (Zip Code)

                                  719-575-0044
-----------------------------------------------------------------------------
               (Registrants telephone number, including area code)

                                                            
-----------------------------------------------------------------------------
Former name, former address and former fiscal year, if changed since last
report)

Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by section 13 or 15 (d) of the Securities Exchange Act 
of 1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days.   Yes   X        No 
                                                     -----         -----

                       APPLICABLE ONLY TO ISSUERS INVOLVED
                        IN BANKRUPTCY PROCEEDINGS DURING
                            THE PRECEDING FIVE YEARS

Indicate by check mark whether the registrant has filed all documents and 
reports required to be filed by section 13 or 15 (d) of the Securities 
Exchange Act of 1934 subsequent to the distribution requirements under a plan 
confirmed by a court.   Yes          No 
                            -----       -----

                      APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
  Class                                 Outstanding at August 18, 1997     
  -------------------------------------------------------------------------
  Common Stock, Par-Value                                                  
  -------------------------------------------------------------------------
  $.001 per share                       6,234,923
  -------------------------------------------------------------------------

<PAGE>

                               MEDPLUS CORPORATION

                              REPORT ON FORM 10-QSB


                                TABLE OF CONTENTS


PART I                                                    PAGE NUMBER
------                                                    -----------

ITEM 1.  -   FINANCIAL INFORMATION

             Balance Sheets at June 30, 1997
                and March 31, 1997 . . . . . . . . . . . . . . 3

             Statements of Operations for the
                Three Months Ended June 30, 1997 
                and June 30, 1996. . . . . . . . . . . . . . . 5

             Statements of Cash Flows for the 
                Three Months Ended June 30, 1997
                and June 30, 1996. . . . . . . . . . . . . . . 6

             Notes to Financial Statements . . . . . . . . . . 7

ITEM 2. -    MANAGEMENT'S DISCUSSION AND ANALYSIS OF THE
                FINANCIAL CONDITION AND RESULTS OF
                OPERATIONS . . . . . . . . . . . . . . . . . .10

PART II

                Other Information. . . . . . . . . . . . . . .12

                Signature Page . . . . . . . . . . . . . . . .14



                                        2

<PAGE>


                                     PART I
                         ITEM 1.  FINANCIAL INFORMATION
                               MEDPLUS CORPORATION



CONSOLIDATED BALANCE SHEETS

ASSETS                                    June 30, 1997      March 31, 1997
                                            (Unaudited)
CURRENT ASSETS:
Cash and cash equivalents                   $    (4,309)        $     1,920
Accounts receivable                              27,180              24,870
Prepaid expenses and other
    current assets                                6,261               9,851
Inventory                                         3,172
Note receivable from Shareholder                 20,000              20,000
                                            -----------         -----------
Total current assets                             52,304              56,641
                                            -----------         -----------

PROPERTY:
Office Equipment                                 41,729              46,729
Furniture and Fixtures                           21,262              21,264
Leasehold Improvements                           87,785              87,785
                                            -----------         -----------

Total                                           150,776             155,778
Less accumulated depreciation                    36,260              34,045
                                            -----------         -----------

Net property                                    114,516             121,733
                                            -----------         -----------

TOTAL ASSETS                                $   166,820         $   178,374
                                            -----------         -----------
                                            -----------         -----------


                 See accompanying notes to financial statements



                                       3

<PAGE>

MEDPLUS CORPORATION
-------------------

CONSOLIDATED BALANCE SHEETS  CONTINUED
                                          June 30, 1997      March 31, 1997
LIABILITIES AND SHAREHOLDERS' EQUITY        (Unaudited)

CURRENT LIABILITIES:

Accounts payable and accrued
 expenses                                   $   964,335         $   869,590
Notes payable to related parties  (Note 4)      359,435             358,725
Deferred Salaries                                93,327              65,954
Convertible note payable - net of
 discount (Note 4)                               37,500              25,000
Notes payable                                   105,339              84,072
Line of credit                                    4,759               4,327
                                            -----------         -----------

Total liabilities                             1,564,695           1,407,668
                                            -----------         -----------

SHAREHOLDERS' EQUITY:
Preferred stock, $.001 par value;
 authorized 2,000,000 shares;
  no shares outstanding
Common stock, $.001 par value;
 authorized, 30,000,000 shares;
 issued and outstanding, 9,529,740
 and 8,895,278 shares at December 31, 1996
 and March 31, 1996 respectively                  8,322               8,322
Additional paid in capital                    7,493,561           7,459,561
Accumulated deficit                          (8,899,758)         (8,697,177)
                                            -----------         -----------

Net shareholders' equity                     (1,397,875)         (1,229,294)
                                            -----------         -----------


TOTAL                                       $   166,820         $   178,374
                                            -----------         -----------
                                            -----------         -----------


                 See accompanying notes to financial statements


                                       4

<PAGE>

                             MEDPLUS CORPORATION
                    CONSOLIDATED STATEMENTS OF OPERATIONS
                                 (UNAUDITED)


                                                Three Month Period
                                                   Ended June 30,
                                              -------------------------
                                                 1997            1996
                                                 ----            ----

PATIENT FINANCE REVENUES:                     $   5,640       $  46,444

EXPENSES:
General and Administrative                      102,417         166,339
Sales and Marketing                              76,275          67,752


Total expenses                                  178,692         234,091
                                              ---------       ---------
Loss from Operations                           (173,053)       (187,647)



Loss from Continuing Operations                (173,053)
Loss from Discontinued Operations of 
 Occupational Health Clinic                     (29,528)
Net loss                                       (202,581)       (187,647)
                                              ---------       ---------

Loss Per Share From Continuing Operations          (.03)          (0.03)
               From Discontinued Operations        (.00)
Total                                              (.03)          (0.03)
                                              ---------       ---------
                                              ---------       ---------


Weighted average number of
 common shares outstanding                    6,234,923       6,913,021


                    See accompanying financial statements


                                       5

<PAGE>
                               MEDPLUS CORPORATION
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)

                                                        THREE MONTH PERIOD ENDED

                                                                June 30,
                                                           1997          1996
                                                           ----          ----
CASH FLOWS (USED BY) OPERATING ACTIVITIES:
Net loss                                               ($ 202,581)   ($ 187,647)
Adjustments to reconcile net income (loss) to net
 cash from (used) by operating activities:
 Depreciation and amortization                              7,634         1,667
 (Increase) decrease in assets:
       Accounts receivable                                 (2,310)       (1,878)
       Inventory                                                0              
       Prepaid expenses and other current
        assets                                                  2        (5,057)
       Increase (decrease) in liabilities: 
       Accounts payable and accrued expenses               94,745        (5,853)
       Deferred Salaries                                   27,373        (4,849)
                                                       -----------   -----------
Total cash provided (used) by operating activities        (75,137)     (203,617)

CASH FLOWS FROM (USED BY) INVESTING ACTIVITIES:
Investment in property, plant and equipment                              (6,308)
Proceeds from sale of equipment                                               0
Additions to property, plant and equipment                      0             0
                                                       -----------   -----------
Total cash provided (used) by investing activities              0        (6,308)

CASH FLOWS FROM (USED BY) FINANCING ACTIVITIES:
Purchase of short term debt                                67,591        44,000
Purchase of long term debt                                      0             0
Payment on short term debt                                      0       (27,000)
Payment of note payable                                   (32,683)            0
Issuance of common stock                                   34,000       203,829
                                                       -----------   -----------
Total cash from (used by) financing activities             68,908       220,829

Increase (decrease) in cash and cash equivalents           (6,229)       10,904
Cash and cash equivalents at beginning of period            1,920         7,778
                                                       -----------   -----------

Cash and cash equivalents at end of period              $  (4,309)    $  18,682
                                                       -----------   -----------
                                                       -----------   -----------

                                         6
<PAGE>

                               MEDPLUS CORPORATION

                    NOTES TO FINANCIAL STATEMENTS (UNAUDITED)

1.   GOING CONCERN

     The accompanying unaudited consolidated financial statements have been
     prepared on a going concern basis, which contemplates the realization of
     assets and the satisfaction of liabilities in the normal course of
     business. As reflected in the Company's most recent 10-K for the fiscal
     year ended March 31, 1997, the Company has incurred significant losses from
     operations during the years ended March 31, 1997 and 1996 and at March 31,
     1997 and 1996 have negative working capital and negative shareholders'
     equity. The consolidated financial statements do not include any
     adjustments relating to the recoverability and classification of recorded
     asset amounts or the amounts and classification of liabilities that might
     be necessary  should the Company  be unable to continue as a going concern.
     The Company's continuation as a going concern is dependent upon its ability
     to generate sufficient cash to meet its obligations on a    timely basis,
     to obtain financing as may be required, and ultimately to attain successful
     operations. Management is continuing its efforts to obtain additional funds
     needed for the successful operation of the Company. See Item 2. 
     Management's Discussion and Analysis of Financial Condition and Results of 
     Operations to review management's attempt to solve the cash flow needs of 
     the Company.

2.   BASIS OF PRESENTATION

     The accompanying unaudited consolidated financial statements of MEDPLUS
     CORPORATION contain all adjustments (consisting of only normal recurring
     adjustments) which, in the opinion of management are necessary to present
     fairly the financial position of the Company as of the periods ended June
     30, 1997 and March 31, 1997, and the results of operations and its cash    
     flows for the three month periods ended June 30, 1997 and June 30, 1996.
     Certain   information and footnote disclosures normally included in
     financial statements have been     condensed or omitted pursuant to rules
     and regulations of the Securities and Exchange    Commission, although the
     registrant believes that the disclosures in the consolidated financial     
     statements are adequate to make the information presented not misleading.

     INCOME TAXES - As of March 31, 1997 the Company has net operating loss
     carryforwards of approximately $2,362,000, which can be utilized in future
     periods to offset future taxable income. The net operating loss
     carryforwards begin expiring in the year 2000. Due to the Company's net    
     operating loss position and carryforwards the adoption of SFAS 109 has no
     material impact.

     Operating results for the three months ended June 30, 1997 are not 
     necessarily indicative of the results for the year ending March 31, 1998.

     The unaudited consolidated financial statements included herein should be
     read in conjunction with the consolidated financial statements of the
     Company for the year ended March 31, 1997, included in the Company's Annual
     Report on Form 10-K.

3.   COMPUTATION OF NET LOSS PER SHARE

     Net loss per share is computed by dividing net loss by the weighted average
     number of shares of common stock outstanding. Options and warrants are not
     included because their effect would be antidilutive.

                                       7
<PAGE>

4. NOTES PAYABLE TO RELATED PARTIES

   Notes payable to related parties all of which are considered to be current
liabilities by their term or due to default consists of the following at 
June 30, 1997 and March 31, 1997:

                                                 June 30, 1997   March 31, 1997
                                                 -------------   --------------
                                                   Unaudited
   Unsecured note payable to Company
     director bearing interest at 10% per 
     annum, $10,000 together with
     accrued interest and $15,000 together
     with accrued interest.                                            
                                                     25,000            25,000
 
   Unsecured note payable to a former officer and
     director of the Company bearing interest
     at 18% per annum. The note is past due 
     and is currently under dispute.                 40,500            40,500
 
   Unsecured note payable to a shareholder and
     former officer of the Company, non-interest
     bearing, due in equal monthly
     installments of $2,000 from May 1996
     through April 1997 with a final installment
     of $123,288 payable in May 1997. This note
     is recorded net of unamortized discount of
     $5,074 at March 31, 1997 to reflect an
     effective interest rate of 18%. Payments
     on this note are in default.                   137,970           157,763
 
   Unsecured note payable to shareholders of the
     Company bearing interest at 10% per
     annum.  The note is payable on demand.         109,780           103,962
 
   Unsecured note payable to shareholder of the
     Company bearing interest at 11% per
     annum.  The note is payable on demand.          12,185            12,500
 
   Unsecured note payable to shareholder of the
     Company bearing interest at a range
     between 10% and 17%, depending on
     shareholder's credit card rate.  The note
     is payable on demand.                           34,000            19,000

  Total                                           $ 359,435         $ 358,725

                                        8
<PAGE>

  CONVERTIBLE NOTES PAYABLE

  During 1997, the Company issued $100,000 of convertible notes due October
  1, 2006 bearing interest at 8% per annum.  Upon closing of an anticipated
  public offering of common stock, the noteholders have thirty days to
  convert the notes into shares of common stock of the Company in face value
  amount equal to 200% of the dollar amount of the notes based on the per
  share price of the common stock as set forth in the anticipated public
  offering.  In the event the planned public offering has not become
  effective by October 1, 1997, the noteholders may, at their sole option,
  elect to convert the notes and all accrued interest into share of common
  stock of the Company based on the closing price per share at the close of
  business on the last business day of the month in which the notice is
  received by the transfer agent.  Payments of accrued interest are payable
  on April 1 and October 1.  The Company is in default on the interest
  payments as of July 24, 1997.

  In order to recognize the beneficial conversion feature to the noteholders
  of these convertible notes, the Company has recorded the $100,000 excess
  value of the common stock to be issued upon the anticipated conversion of
  the notes over the face value as a note discount and additional paid-in
  capital.  The discount is being amortized to interest expense from the
  issuance date through October 1, 1997.

  During the year ended March 31, 1997, $50,000 of the convertible notes were
  converted into 256,410 shares of common stock.  At the date of conversion,
  $50,000 of unamortized discount was charged to interest expense with a
  corresponding increase to common stock and additional paid-in capital.

  NOTES PAYABLE 

  Notes payable, all of which are current liabilities by their terms, consist
  of the following:

                                                  June 30, 1997  March 31, 1997
                                                  -------------  --------------
                                                    Unaudited
  
  Unsecured note payable to an individual
    bearing interest at 12%, interest
    payable monthly and due August 1997.              47,108         49,072


  Unsecured note payable to an individual
    bearing interest at 12%, interest
    payable monthly and due August 1997.              25,000              0

  Note payable to bank bearing interest at
    9.875%, collateralized by certain assets
    of a shareholder and due June 1997.               33,231         35,000

  Unsecured $5,000 line of credit bearing 
    interest at 15%.                                   4,759          4,327
          

  Total                                            $ 110,098       $ 88,399
                                                   ---------       --------

                                       9
<PAGE>
                                       
               ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                 FINANCIAL CONDITION AND RESULTS OF OPERATIONS

LIQUIDITY AND CAPITAL RESOURCES

At June 30, 1997 the Company had working capital of ($1,512,391) compared to 
working capital of ($1,351,027) at March 31, 1997.  The decline in working 
capital is primarily due to the Company's net loss for the three months ended 
June 30, 1997.  The Company's current liabilities are higher than its assets 
due primarily to borrowings in the form of promissory notes from shareholders 
of the Company and related parties along with accrued payables and expenses.

The Company's liquidity position is severely strained.  Liquidity needs are 
currently being met from revenues and short-term borrowing in the form of 
promissory notes.  Because the Company has not achieved positive cash flow 
from its operating activities, the Company's ability to continue operations 
is dependent upon its ability to raise additional equity and/or debt 
financing. This and other factors raise substantial doubt as to the Company's 
ability to continue as a going concern.  Management believes the Company 
needs approximately $ 2,000,000 in equity or debt financing in order to 
sustain operations for the next twelve months following the period ended June 
30, 1997. On or about April 8, 1997, the Company entered into a financing 
agreement with Sands Brothers & Co., Inc., to provide debt/equity financing 
which would be more than sufficient to operate the Company and fulfill its 
business plans.  The proceeds of this offering will be utilized to expand the 
Company's marketing activities, for future acquisitions and to reduce the 
Company's debt. Sands Brothers & Co., Inc. has informed the company that they 
will commence its fund raising activities immediately upon the filing of the 
company's Form 10-QSB. Although the Company is actively engaged in activities 
with intent to raise equity and/or debt financing in order to meet its 
long-term liquidity needs, there can be no assurance that the Company will be 
able to consummate the transaction and/or raise the additional financing 
necessary for continuing operations.  As of June 30, 1997 there were no known 
demands, commitment or uncertainties affecting cash flows other than normal 
accounts payable demands, debt, and past due interest payments.

RESULTS OF OPERATIONS

Revenue derived from the sale of products from the Company's continuing 
operations was $5,640 for the three month period ended June 30, 1997 as 
compared to $46,444 in operating revenue for the three month period ended 
June 30, 1996. The Company's revenue decrease over the three month period 
ended June 30, 1996 is primarily attributable to nonpayment of the Company's 
revenue from United States Bank of Oregon.  The Company's loan volumes 
generated to United States Bank of Oregon have increased. However, United 
States Bank of Oregon has unilaterally decided to withhold the revenues owed 
the Company.  The Company is currently in dispute with United States Bank of 
Oregon, and with Care Card Northwest, over the withholding of the Company's 
revenues and is exploring remedies to this dispute including the possibility 
of legal action.  Revenue derived from discontinued operations was $70,179 
for the three month period ended June 30, 1997.  There was no income from 
discontinued operations for the three month period ended June 30,1996.

General and administrative expenses from continued operations decreased  38% 
from $166,339 during the three month period ended June 30, 1996 to $102,417 
during the three month period ended June 30, 1997. The decrease of 38% 
during the three month period ended June 30, 1997 is due primarily to 
decreases in personnel after the United States Bank withholding the company's 
revenues as stated above.  

                                      10
<PAGE>

Sales and marketing expenses for continued operations increased 13% from 
$67,752 during the three month period ended June 30, 1996 to $76,275 during 
the three month period ended June 30, 1997.  The increase of 13% during the 
three month period ended June 30, 1997 is primarily due to  the addition of 
sales and marketing personnel and related expense for the Company's health 
care credit card services field offices in California in support of the 
Company's new product.

                                      11
<PAGE>

                                   PART II
                              OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

     See Form 10-KSB regarding litigation no changes for period ending June 30,
     1997

ITEM 2. CHANGES IN SECURITIES

     None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

     None

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITIES HOLDERS

     None

ITEM 5. OTHER INFORMATION

     On or about March 3, 1997 with the program commencing on May 9th signed 
an Affinity Agreement with Pullman Bank & Trust Company.  The Company and 
Bank intend to establish a Private Label and/or MasterCard, and/or Visa Card 
account program generally referred to in the industry as a 
"co-branded/affinity card", which provides the Company with certain benefits 
paid by Bank to Company and/or certain benefits paid by Company to Bank as a 
result of Company's members or customers using a Private Label and/or 
MasterCard, and/or Visa Card issued by Bank to members who participate in the 
program.  The initial program issues a Private Label MedPlus Card to all 
customers who apply.

     On or about March 5, 1997 signed a Letter of Intent with R.J. 
Associates, Inc.  R.J. Associates, Inc. is in the business of contracting and 
marketing their own Preferred Provider Network (PPN), Health Payors 
Organization, LTD., and Competitive Health Plan, Inc. which together compose 
approximately 80,000 physicians, 2,000 medical surgical hospitals and 5,000 
ancillary facilities, most of whom are directly contracted.  The Letter of 
Intent calls for the Company and R.J. Associates, Inc. to enter into an 
agreement whereas the Company can expand utilization of its credit card by 
marketing health insurance with its credit card and utilize the discount for 
service PPN owned by R.J. Associates, Inc.

     On April 8, 1997, the Company executed a three year exclusive investment 
banking agreement (the "Letter") with Sands Brothers located in New York.  As 
spelled out in the agreement Sands Brothers' duties may include, but will not 
necessarily be limited to:  (i)  advice regarding formation of corporate 
goals and their implementation;  (ii) advice regarding the financial 
structure of the Company, its divisions or subsidiaries or any programs and 
projects undertaken by the Company;  (iii)  advice regarding the securing, 
when necessary and if possible, of financing (other than with respect to a 
Financing 

                                      12
<PAGE>

Transaction);  (iv)  advice regarding corporate organization, personnel and 
selection of needed specialty skills; and  (v)  review of possible joint 
venture, merger, acquisition or similar proposals for the Company (other than 
with respect to an Acquisition Transaction).

     On May 9, 1997, the Company effectuated a one for three reverse stock 
split, whereby shareholders received one share of common stock for every 
three shares of common stock held of record.  Fractional shares were rounded 
upward to the next full share.

     On July 28, 1997, the Company announced its decision to divest itself of 
the occupation medicine clinic to focus on its core business.  While there 
currently is not a suitable buyer, the Company intends to sell the clinic by 
March 31, 1998, and should not incur a loss.

     As a subsequent event, in July, 1997 the company raised $150,500 through 
two accredited investors through a promissory note.  As a part of this 
agreement the company issued  warrants to purchase shares of common stock in 
the amounts of  45,000 shares and 25,000 shares.  The warrants issued are 
exersisable at $ .50 and $1.00 respectively and are two year terms.  The 
capital raised was used for general working capital purposes.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

     a.  Exhibits
         None

     b.  Reports on Form 8-k
         None
  









                                      13
<PAGE>

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.


                                        MEDPLUS CORPORATION


                                        
Date:  August 20,1997                   \By\Tim C. DeHerrera
                                        -----------------------------
                                        Tim C. DeHerrera
                                        Chief Executive Officer

Date:  August 20, 1997                  \By\Jim Harding
                                        -----------------------------
                                        Jim Harding
                                        Chief  Financial Officer







                                      14